Research analysts at StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a report released on Sunday. The firm set a “sell” rating on the stock.
Ampio Pharmaceuticals Price Performance
AMPE stock opened at $0.00 on Friday. Ampio Pharmaceuticals has a 12-month low of $0.00 and a 12-month high of $7.47. The company has a market cap of $2,497.00, a PE ratio of 0.00 and a beta of 3.67.
Ampio Pharmaceuticals Company Profile
Further Reading
- Five stocks we like better than Ampio Pharmaceuticals
- What is the S&P/TSX Index?
- Ciena Stock Powers the AI Cloud Boom—Don’t Miss Out
- Where Do I Find 52-Week Highs and Lows?
- Affirm’s Path to Profitability Elevates with Interest Rate Cuts
- Canada Bond Market Holiday: How to Invest and Trade
- RPM International Thrives in Rate-Cut Driven Construction Rally
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
